These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23734938)

  • 21. Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction.
    Sconocchia G; Spagnoli GC; Del Principe D; Ferrone S; Anselmi M; Wongsena W; Cervelli V; Schultz-Thater E; Wyler S; Carafa V; Moch H; Terracciano L; Tornillo L
    Neoplasia; 2009 Jul; 11(7):662-71. PubMed ID: 19568411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic implications of CD14 positivity in acute myeloid leukemia arising from myelodysplastic syndrome.
    Choi Y; Lee JH; Kim SD; Kim DY; Lee JH; Seol M; Kang YA; Jeon M; Jung AR; Lee KH
    Int J Hematol; 2013 Feb; 97(2):246-55. PubMed ID: 23371544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential Expression of CD52, CD14 and HLA-DR on CD4+ Monocytes in Three Types of Acquired Bone Marrow Failure Syndromes.
    Kai Y; Yuanyuan D; Shihe G; Xuanxuan M; Hao Z; Ying P; Yuanyuan W; Aihua W; Beibei S; TongYang ; Tingdong Z
    Clin Lab; 2016 Sep; 62(9):1767-1772. PubMed ID: 28164595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Subtype and Functional Biomarker Changes of NK Cells in Peripheral Blood of Patients with Myelodysplastic Syndrome].
    Xu SJ; Shao ZH; Fu R; Wang HQ; Liu H; Liu CY; Zhang W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):832-836. PubMed ID: 28641645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes.
    Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE
    Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors.
    Epling-Burnette PK; Bai F; Painter JS; Rollison DE; Salih HR; Krusch M; Zou J; Ku E; Zhong B; Boulware D; Moscinski L; Wei S; Djeu JY; List AF
    Blood; 2007 Jun; 109(11):4816-24. PubMed ID: 17341666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
    Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F
    J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
    Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
    EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of bone marrow and peripheral blood immunoregulatory lymphocytes in patients with myelodysplastic syndrome.
    Iwase O; Aizawa S; Kuriyama Y; Yaguchi M; Nakano M; Toyama K
    Ann Hematol; 1995 Dec; 71(6):293-9. PubMed ID: 8534761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes.
    Hejazi M; Manser AR; Fröbel J; Kündgen A; Zhao X; Schönberg K; Germing U; Haas R; Gattermann N; Uhrberg M
    Haematologica; 2015 May; 100(5):643-52. PubMed ID: 25682594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.
    Heatley SL; Pietra G; Lin J; Widjaja JML; Harpur CM; Lester S; Rossjohn J; Szer J; Schwarer A; Bradstock K; Bardy PG; Mingari MC; Moretta L; Sullivan LC; Brooks AG
    J Biol Chem; 2013 Mar; 288(12):8679-8690. PubMed ID: 23335510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease.
    Kordelas L; Steckel NK; Horn PA; Beelen DW; Rebmann V
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of development of CD56 bright CD11c + NK-like cells with helper function by IL-18.
    Li W; Okuda A; Yamamoto H; Yamanishi K; Terada N; Yamanishi H; Tanaka Y; Okamura H
    PLoS One; 2013; 8(12):e82586. PubMed ID: 24376549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.
    O'Callaghan CA
    Microbes Infect; 2000 Apr; 2(4):371-80. PubMed ID: 10817639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells.
    Mrózek E; Anderson P; Caligiuri MA
    Blood; 1996 Apr; 87(7):2632-40. PubMed ID: 8639878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease.
    Jabri B; de Serre NP; Cellier C; Evans K; Gache C; Carvalho C; Mougenot JF; Allez M; Jian R; Desreumaux P; Colombel JF; Matuchansky C; Cugnenc H; Lopez-Botet M; Vivier E; Moretta A; Roberts AI; Ebert EC; Guy-Grand D; Brousse N; Schmitz J; Cerf-Bensussan N
    Gastroenterology; 2000 May; 118(5):867-79. PubMed ID: 10784586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescence in situ hybridization to cells collected by means of fluorescence-activated cell sorting.
    Miura I; Kobayashi Y; Takahashi N; Saitoh K; Miura AB
    Br J Haematol; 2000 Sep; 110(4):876-9. PubMed ID: 11054073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of CD56+ cutaneous aleukaemic granulocytic sarcoma with myelodysplastic syndrome.
    Murakami Y; Nagae S; Matsuishi E; Irie K; Furue M
    Br J Dermatol; 2000 Sep; 143(3):587-90. PubMed ID: 10971333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications.
    García-Sanz R; González M; Orfão A; Moro MJ; Hernández JM; Borrego D; Carnero M; Casanova F; Bárez A; Jiménez R; Portero JA; San Miguel JF
    Br J Haematol; 1996 Apr; 93(1):81-8. PubMed ID: 8611480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants.
    Carretero M; Palmieri G; Llano M; Tullio V; Santoni A; Geraghty DE; López-Botet M
    Eur J Immunol; 1998 Apr; 28(4):1280-91. PubMed ID: 9565368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.